Indication for PEDIARIX

PEDIARIX is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. PEDIARIX is approved for use as a three-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative mothers. PEDIARIX may be given as early as 6 weeks of age through 6 years of age (prior to the 7th birthday).

Count on PEDIARIX to continue your DTaP immunization routine without interruption*

(noun) the ability to continue your DTaP immunization routine with the support of PEDIARIX*,†

As in the phrase: “With PEDIARIX, I have the contimmunity my practice needs to avoid disruption of my DTaP immunization routine.”

Count on PEDIARIX to continue your DTaP
immunization routine without interruption*

(noun) the ability to continue your DTaP immunization routine with the support of PEDIARIX*,†

As in the phrase: “With PEDIARIX, I have the contimmunity my practice needs to avoid disruption of my DTaP immunization routine.”

  DTaP=diphtheria, tetanus, and acellular pertussis.
* Data are not available on the safety and effectiveness of using PEDIARIX following one or more doses of a DTaP vaccine from a different manufacturer.
Does not imply immunity or duration of immunity beyond that which was demonstrated in clinical trials for PEDIARIX.

Chat